Published in Gynecol Oncol on February 16, 2010
Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy? Gynecol Oncol (2010) 1.46
The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology (2010) 1.45
Fertility-sparing surgery for early-stage cervical cancer. Int J Surg Oncol (2012) 0.96
Questionnaire survey of the current status of radical trachelectomy in Japan. Int J Clin Oncol (2010) 0.91
Radical trachelectomy: the first step of fertility preservation in young women with cervical cancer (Review). Oncol Rep (2013) 0.83
Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancer. Eur Radiol (2015) 0.80
Influencing surgical management in patients with carcinoma of the cervix using a T2- and ZOOM-diffusion-weighted endovaginal MRI technique. Br J Cancer (2013) 0.79
Fertility preservation in women with cervical, endometrial or ovarian cancers. Gynecol Oncol Res Pract (2016) 0.78
Sexual and Reproductive Outcomes in Early Stage Cervical Cancer Patients after Excisional Cone as a Fertility-sparing Surgery: An Italian Experience. J Reprod Infertil (2014) 0.76
Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success. Gynecol Oncol Res Pract (2016) 0.76
Simple trachelectomy of early invasive cervix carcinoma in the second trimester. J Turk Ger Gynecol Assoc (2011) 0.75
Is MRI helpful in assessing the distance of the tumour from the internal os in patients with cervical cancer below FIGO Stage IB2? Clin Radiol (2016) 0.75
The effect of abdominal radical trachelectomy on ovarian reserve: serial changes in serum anti-müllerian hormone levels. J Cancer (2012) 0.75
Laparoscopic radical trachelectomy: technique, feasibility, and outcomes. JSLS (2015) 0.75
Oncologic and obstetric outcomes and complications during pregnancy after fertility-sparing abdominal trachelectomy for cervical cancer: a retrospective review. Int J Clin Oncol (2016) 0.75
Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis. Oncotarget (2017) 0.75
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer. J Clin Oncol (2011) 2.62
Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecol Oncol (2002) 2.23
Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses. Cancer (2007) 1.45
Sentinel lymph node in vulvar cancer. Cancer (2007) 1.44
Sentinel lymph nodes. Cancer (2003) 1.38
Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy. Gynecol Oncol (2003) 1.08
Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer. Nat Clin Pract Oncol (2007) 0.99
Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gynecol (2003) 0.98
Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma. Cancer (2003) 0.92
Feasibility of same-day discharge after laparoscopic surgery in gynecologic oncology. Gynecol Oncol (2011) 0.90
Role of sentinel lymph node biopsy in cervical cancer: pro. Int J Gynecol Cancer (2010) 0.89
Surgery for early stage cervical cancer: how radical should it be? Gynecol Oncol (2013) 0.86
Systematic review of adjuvant care for women with Stage I ovarian carcinoma. Cancer (2004) 0.85
Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet. J Reprod Med (2004) 0.85
Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings. Oncol Rep (2007) 0.81
Intraoperative consultation in gynecologic pathology: a 6-year audit at a tertiary care medical center. Int J Gynecol Cancer (2009) 0.81
Vaginal vault dehiscence and increased use of vaginal vault brachytherapy: what are the implications? Int J Gynecol Cancer (2012) 0.81
State of the art of sentinel lymph node biopsy in vulvar carcinoma. Womens Health (Lond Engl) (2009) 0.80
Is routine appendectomy at the time of primary surgery for mucinous ovarian neoplasms beneficial? Int J Gynecol Cancer (2013) 0.80
Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion. Ann Diagn Pathol (2007) 0.78
Total mesometrial resection for cancer of the cervix: the future surgical procedure, or oblivion? Lancet Oncol (2009) 0.77
Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma. Int J Gynecol Pathol (2007) 0.77
Cytoreductive surgery for recurrent ovarian cancer. Curr Opin Obstet Gynecol (2007) 0.77
Quality control in sentinel lymph node biopsy in cervical cancer. J Clin Oncol (2008) 0.76
Advancing fertility-sparing treatments in cervical cancer: where is the limit? Gynecol Oncol (2012) 0.75
Follow-up after chemoradiation for cervical cancer: Why? Cancer (2011) 0.75
Conservative surgery for early stage cervical cancer: who should we offer it to? Gynecol Oncol (2010) 0.75
Imaging of lymph node metastases in cervical cancer. CMAJ (2008) 0.75
Determining the role of a national objective assessment of surgical skills in gynecological oncology: an e-Delphi methodology. Int J Gynecol Cancer (2014) 0.75
Chemotherapy-induced alterations in ovarian sex cord tumor with annular tubules (SCTAT): a diagnostic challenge. Pathol Res Pract (2006) 0.75
How Common Is the Growing Teratoma Syndrome in Patients With Ovarian Immature Teratoma? Int J Gynecol Cancer (2016) 0.75
Lymphatic vessel density as a prognostic marker in clinical stage I endocervical adenocarcinoma. Int J Gynecol Pathol (2010) 0.75
Postradical vaginal trachelectomy follow-up by isthmic-vaginal smear cytology: a 13-year audit. Diagn Cytopathol (2009) 0.75